HealthEquity (NASDAQ: HQY) reported Q2 EPS of $1.08, $0.16 better than the analyst estimate of $0.92. Revenue for the quarter came in at $325.8 million versus the consensus estimate of $320.74 million.

GUIDANCE:

HealthEquity sees FY2026 EPS of $3.74-$3.91, versus the consensus of $3.73. HealthEquity sees FY2026 revenue of $1.29-1.31 billion, versus the consensus of $1.305 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.